Priveterra Acquisition Corp. (PMGM) Completes AEON Biopharma Deal
Priveterra Acquisition Corp. (Nasdaq: PMGM) announced this afternoon that it has completed its business combination with AEON Biopharma.
The news follows the SPAC’s eight consecutive adjournments of the completion vote. However, during this period, Priveterra managed to secure up to $105 million in new funding through a mix of facilities.
...READ MORE